1. Market Research
  2. > Business Services
  3. > Business Outsourcing Market Trends

Clinical Development Outsourcing Models (2nd edition)

  • October 2015
  • 82 pages
  • Industry Standard Research
Report ID: 3783203

Summary

Table of Contents

Report Overview

Most pharma companies no longer outsource simply because they have to Most now recognize value in the use of contract organizations But while the evolution of pharma’s outsourcing philosophy has been
fairly uniform across companies, the application of outsourcing strategy remains highly diverse The real trick for a head of R&D is identifying which model is best given the particular pharma company’s culture,
infrastructure for clinical trial management, infrastructure for CRO management, depth of pipeline, and a host of other factors

Methodology:

ISR surveyed 107 respondents who:

• Currently work at a pharma or biotech company with annual R&D expenditure of at least $100M
• Have responsibility for outsourcing clinical trials
• Are somewhat to highly knowledgeable about their company’s clinical development outsourcing model

Report Structure:

Executive Summary

Clinical Development Outsourcing Dynamics
• Outsourcing Cost Breakdown by Function
• Outsourcing Difficulties
• In-House and Outsourcing Model Allocation
• Preferred Service Provider Type by Phase
• Roles and Responsibilities that Influence Service Provider Selection
Outsourcing Models: Performance, Selection, and Use
• Analysis of each outsourcing model evaluated including model performance and reasons for use
Future Trends
• Likelihood to Deviate from Current Model
• Likelihood to Change Service Providers Based on Trends
Study Data

Outsourcing Models Evaluated:

• Preferred Provider Outsourcing
• In-Sourcing Clinical Development Staff
• Fee-For-Service Outsourcing
• Functional Service Provider (FSP) Outsourcing
• Compound or Program-Based Outsourcing
• Hybrid Full Service and FSP Outsourcing
• Sole-Source Outsourcing

What you will learn in this report:

Benefits for each major outsourcing model

• Percentage of outsourcing volume each model currently represents and predictions for future trends
• Sponsor satisfaction, reasons for selection, and details for how each model is used

How you can use this report:

• For Study Sponsors: Pharma buyers of this report are encouraged to use its content to navigate the benefits and drawbacks of available outsourcing models by examining what’s working and not working for other companies and why
• For Service Providers: Service providers are encouraged to use the report’s content to plan for the rise of some models, the decline of others, identify the drivers of success for these models, and anticipate customers’ need accordingly

Introduction

Outsourcing in the pharmaceutical industry is no longer in its infancy The past 25 years have witnessed an evolution in pharma R&D management strategy Outsourcing penetration for development activities now stands at >60% Most pharma companies no longer outsource simply because they have to Most now recognize value in the use of contract organizations Sure, many individuals still hold strong preferences for using in-house resources to run clinical trials, but these attitudes tend to reside deep within operational functions; much less within executive management where R&D strategies are formed Additionally, where outsourcing once was limited to the buying of “hands and feet” – supplemental resources – organizations now regularly purchase experience and guidance (they still don’t like the word “strategy”)

But while the evolution of pharma’s outsourcing philosophy has been fairly uniform across companies, the application of outsourcing strategy remains highly diverse Many approaches to the use of CROs remain in play for those responsible for R&D strategy

The most common among them include:

preferred provider agreements, one-off fee-for-service agreements, functional service provider agreements, large scale single-source partnerships, and a few others of merit
ISR’s data in the current report show – in our judgment – acceptable levels of satisfaction for most outsourcing models The real trick for a head of R&D is not identifying which model is best, but rather, which model is best given the particular pharma company’s culture, infrastructure for clinical trial management, infrastructure for CRO management, depth of pipeline, and a host of other factors

Pharma buyers of this report are encouraged to use its content to navigate the benefits and drawbacks of available outsourcing models by examining what’s working and not working for other companies and why
Service providers are encouraged to use the report’s content to plan for the rise of some models, the decline of others, identify the drivers of success for these models, and anticipate customers’ need accordingly

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Knowledge Process Outsourcing Market Analysis By Service, By Application, By Region And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • August 2017
  • by Grand View Research

Knowledge Process Outsourcing (KPO) Market Analysis By Service, By Application (BFSI, Healthcare, IT & Telecom, Manufacturing, Pharmaceutical, Retail), By Region, And Segment Forecasts, 2014 - 2025 The ...

Regulatory Affairs Outsourcing Market Analysis By Service And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • August 2017
  • by Grand View Research

Regulatory Affairs Outsourcing Market Analysis By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Application), And Segment ...

Global Automation After Services and Outsourcing Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • August 2017
  • by Accuray Research LLP

The Global Automation Aftermarket Services and Outsourcing Market is poised to grow at a CAGR of around XX% during the forecast period 2016 to 2025. Some of the prominent trends that the market is witnessing ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.